HFM
ABUS icon

Hartford Financial Management’s Arbutus Biopharma ABUS Stock Holding History

Hartford Financial Management’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.05K Hold
900
– – ﹤0.01% 306
2025
Q4 		$4.33K Hold
900
– – ﹤0.01% 301
2025
Q3 		$4.09K Hold
900
– – ﹤0.01% 303
2025
Q2 		$2.78K Hold
900
– – ﹤0.01% 310
2025
Q1 		$3.14K Hold
900
– – ﹤0.01% 318
2024
Q4 		$2.94K Hold
900
– – ﹤0.01% 339
2024
Q3 		$3.46K Hold
900
– – ﹤0.01% 340
2024
Q2 		$2.78K Buy
+900
New +$2.7K ﹤0.01% 346

Other funds holding ABUS

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
WCM
Whitefort Capital Management New York $339M AUM 52.48% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return